Synthetic chemicals known as PFAS linked to liver damage

Exposure to a class of widely used synthetic chemicals is connected to liver damage according to a new study conducted by researchers from the Keck School of Medicine of USC and published on April 27 in Read More »

April 28th, 2022|Announcements, Keck Net Intranet|

Distinguished filmmaker and laryngectomy patient recognized for cinematic advocacy

In 2016, Peabody Award-winning and Emmy-nominated filmmaker Bill Brummel started having severe breathing problems. His airway, doctors found, was almost completely closed due to the long-term side effects of radiation treatment Brummel received for tonsil cancer 24 years ago.

To save Read More »

April 27th, 2022|Announcements, Keck Net Intranet|

Study reveals that AI could help liver transplant patients with alcohol use disorder

A screening tool developed with artificial intelligence and trained on hundreds of hours of patient interviews could flag risks for relapse in liver transplant patients with alcohol use disorder — and prompt precise interventions, according to a new study from Read More »

April 27th, 2022|Announcements, Keck Net Intranet|

Perspective: Meditation as a valuable treatment for chronic back pain

Steven Richeimer, MD, is a renowned specialist on issues related to chronic pain. He is the chief of the division of pain medicine at Keck Medicine of USC and a professor of clinical anesthesiology and psychiatry and Read More »

April 27th, 2022|Announcements, Keck Net Intranet|

Keck Medicine researcher leading clinical trial to expand cutting-edge treatment access for depression patients

Since 2005, vagus nerve stimulation (VNS) therapy has been approved by the Food and Drug Administration (FDA) as a safe and effective treatment option for treatment resistant depression. It has been tested in several research studies, including one at Read More »

April 25th, 2022|Announcements, Keck Net Intranet|